Katherine Vega Stultz

Katherine Vega Stultz is a seasoned executive with extensive experience in the biopharmaceutical industry, currently serving as the Founder and Strategic Advisor at Keoe since July 2024. As a board member of Kronos Bio since April 2023, Katherine contributes to the Audit and Compensation Committees. Previously, Katherine was the President and CEO of Ocelot Bio, leading therapeutic advancements for liver disease patients, and held the position of Chief Operating Officer at Graphite Bio, where Katherine was instrumental in its rapid transition to IPO. Katherine's earlier roles at Celgene included General Manager for Spain and Portugal, alongside significant leadership positions in global project management and brand development. Katherine's career began at Eli Lilly and Company and ConvaTec, supported by a Bachelor of Science degree in Mechanical Engineering with a concentration in Biomedical Applications from Cornell University.